Skip to main content

Advertisement

SpringerLink
Log in

Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

To investigate the outcomes of patients with colorectal cancer and initially unresectable or not optimally resectable liver metastases, who were treated using the liver-first approach in the era of modern chemotherapy in Japan.

Methods

We analyzed and compared data retrospectively on patients with asymptomatic resectable colorectal cancer and initially unresectable or not optimally resectable liver metastases, who were treated either using the liver-first approach (n = 12, LF group) or the primary-first approach (n = 13, PF group).

Results

Both groups of patients completed their therapeutic plan and there was no mortality. Postoperative morbidity rates after primary resection and hepatectomy, and post-hepatectomy liver failure rate were comparable between the groups (p = 1.00, p = 0.91, and p = 0.55, respectively). Recurrence rates, median recurrence-free survival since the last operation, and 3-year overall survival rates from diagnosis were also comparable between the LF and PF groups (58.3 vs. 61.5 %, p = 0.87; 10.5 vs. 18.6 months, p = 0.57; and 87.5 vs. 82.5 %, p = 0.46, respectively).

Conclusions

The liver-first approach may be an appropriate treatment sequence without adversely affecting perioperative or survival outcomes for selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg. 2006;93:465–74.

    Article  CAS  PubMed  Google Scholar 

  2. Steele GJ, Ravikumar TS. Resection of hepatic metastases from colorectal metastases: biologic perspectives. Ann Surg. 1989;210:127.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Jaeck D, Bachellier P, Guiguet M, Boudjema K, Vaillant JC, Balladur P, et al. Long-term survival following resection of colorectal hepatic metastases. Br J Surg. 1997;84:977.

    Article  CAS  PubMed  Google Scholar 

  4. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg. 1995;19:59.

    Article  CAS  PubMed  Google Scholar 

  5. Stangl R, Alterndorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994;343:1405.

    Article  CAS  PubMed  Google Scholar 

  6. Stattner S, Primavesi F, Yip VS, Jones PR, Ofner D, Malik HZ, et al. Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience. Surg Today. 2015;45:407–15.

    Article  PubMed  Google Scholar 

  7. Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol. 2010;11:38–47.

    Article  CAS  PubMed  Google Scholar 

  8. Beppu T, Miyamoto Y, Sakamoto Y, Imai K, Nitta H, Hayashi H, et al. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival. Ann Surg Oncol. 2014;21:405–13.

    Article  Google Scholar 

  9. Nordlinger B, Van Cutsem E, Gruenberger T, Glimelius B, Poston G, Rougier P, European Colorectal Metastases Treatment Group, Sixth international Colorectal Liver Metastases Workshop, et al. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol. 2009;20:985–92.

    Article  CAS  PubMed  Google Scholar 

  10. Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, et al. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol. 2007;14:3481–91.

    Article  PubMed  Google Scholar 

  11. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg. 2006;93:872–8.

    Article  CAS  PubMed  Google Scholar 

  12. Beppu T, Sakamoto Y, Hasegawa K, Honda G, Tanaka K, Kotera Y, et al. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for hepatic surgery of the Japanese society of hepato-biliary-pancreatic surgery. J Hepatobiliary Pancreat Sci. 2012;19:72–84.

    Article  PubMed  Google Scholar 

  13. Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125–35.

    Article  PubMed  Google Scholar 

  14. Ayez N, Burger JWA, van der Pool AE, Eggermont AMM, Grunhagen DJ, de Wilt JHW, et al. Long-term results of the “liver first” approach in patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum. 2013;56:281–7.

    Article  PubMed  Google Scholar 

  15. Mentha G, Roth AD, Terraz S, Giostra E, Gervaz P, Andres A, et al. ‘Liver first’ approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg. 2008;25:430–5.

    Article  PubMed  Google Scholar 

  16. Buchs NC, Ris F, Majno PE, Andres A, Cacheux W, Gervaz P, et al. Rectal outcomes after a liver-first treatment of patients with stage IV rectal cancer. Ann Surg Oncol. 2015;22:931–7.

    Article  PubMed  Google Scholar 

  17. de Rosa A, Gomez D, Hossaini S, Duke K, Fenwick SW, Brooks A, et al. Stage IV colorectal cancer: outcomes following the liver-first approach. J Surg Oncol. 2013;108:444–9.

    Article  PubMed  Google Scholar 

  18. Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg. 2010;210:934–41.

    Article  PubMed  Google Scholar 

  19. de Jong MC, van Dam RM, Maas M, Bemelmans MH, Olde Damink SW, Beets GL, et al. The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience. HPB (Oxford). 2011;13:745–52.

    Article  Google Scholar 

  20. Tanaka K, Murakami T, Matsuo K, Hiroshima Y, Endo I, Ichikawa Y, et al. Preliminary results of ‘liver-first’ reverse management for advanced and aggressive synchronous colorectal liver metastases: a propensity-matched analysis. Dig Surg. 2015;32:16–22.

    Article  PubMed  Google Scholar 

  21. Sarela AI, Guthrie JA, Seymour MT, Ride E, Guillou PJ, O’Riordain DS. Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg. 2001;88:1352–6.

    Article  CAS  PubMed  Google Scholar 

  22. Muratore A, Zorzi D, Bouzari H, Amisano M, Massucco P, Sperti E, et al. Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol. 2007;14:766–70.

    Article  PubMed  Google Scholar 

  23. The Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004;350:2050–9.

    Article  Google Scholar 

  24. Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ, COlon cancer Laparoscopic or Open Resection Study Group (COLOR), et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol. 2005;6:477–84.

    Article  PubMed  Google Scholar 

  25. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, MRC CLASICC trial group, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomized controlled trial. Lancet. 2005;365:1718–26.

    Article  PubMed  Google Scholar 

  26. Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11:637–45.

    Article  PubMed  Google Scholar 

  27. van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14:210–8.

    Article  PubMed  Google Scholar 

  28. Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Sekido H, et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery. 2004;136:650–9.

    Article  PubMed  Google Scholar 

  29. McCahill LE, Yothers G, Sharif S, Petrelli NJ, Lai LL, Bechar N, et al. Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. J Clin Oncol. 2012;30:3223–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Faron M, Pignon JP, Malka D, Bourredjem A, Douillard JY, Adenis A, et al. Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials. Eur J Cancer. 2015;51:166–76.

    Article  PubMed  Google Scholar 

  31. Slesser AA, Khan F, Chau I, Khan AZ, Mudan S, Tekkis PP, et al. The effect of a primary tumour resection on the progression of synchronous colorectal liver metastases: an exploratory study. Eur J Surg Oncol. 2015;41:484–92.

    Article  CAS  PubMed  Google Scholar 

  32. Miyamoto Y, Watanabe M, Sakamoto Y, Shigaki H, Murata A, Sugihara H, et al. Evaluation of the necessity of primary tumor resection for synchronous metastatic colorectal cancer. Surg Today. 2014;44:2287–92.

    Article  CAS  PubMed  Google Scholar 

  33. Lam VW, Spiro C, Laurence JM, Johnston E, Hollands MJ, Pleass HCC, et al. A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases. Ann Surg Oncol. 2012;19:1292–301.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Syogoin, Sakyo-ku, Kyoto, 606-8507, Japan

    Masayuki Okuno, Etsuro Hatano, Yosuke Kasai, Takahiro Nishio, Satoru Seo, Kojiro Taura, Kentaro Yasuchika, Takashi Nitta, Akira Mori, Hideaki Okajima, Toshimi Kaido, Suguru Hasegawa, Yoshiharu Sakai & Shinji Uemoto

  2. Department of Clinical Oncology, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Syogoin, Sakyo-ku, Kyoto, 606-8507, Japan

    Shigemi Matsumoto

Authors
  1. Masayuki Okuno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Etsuro Hatano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yosuke Kasai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takahiro Nishio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Satoru Seo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kojiro Taura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kentaro Yasuchika
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takashi Nitta
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Akira Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hideaki Okajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Toshimi Kaido
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Suguru Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Shigemi Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Yoshiharu Sakai
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Shinji Uemoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Etsuro Hatano.

Ethics declarations

Conflict of interest

We have no conflicts of interest to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okuno, M., Hatano, E., Kasai, Y. et al. Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases. Surg Today 46, 721–728 (2016). https://doi.org/10.1007/s00595-015-1242-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-015-1242-z

Keywords

Search

Navigation